Dmitry Gabrilovich

Company: AstraZeneca

Job title: Executive Director, Chief Scientist, Cancer

Bio:

Dr. Dmitry Gabrilovich is a leading immunologist and cancer researcher known for his pioneering work on myeloid-derived suppressor cells (MDSCs) and tumor-induced immune suppression. He currently serves as Executive Director and Chief Scientist at AstraZeneca, where he focuses on developing innovative immuno-oncology strategies. His research has shaped the understanding of myeloid cells in cancer progression and therapy resistance.

Seminars:

Targeting Myeloid Heterogeneity & Ferroptosis: Rethinking Suppression in Pre-Metastatic Niches 9:00 am

Unpack the role of myeloid cell heterogeneity in shaping immunosuppressive premetastatic environments Explore ferroptosis as a regulatory mechanism of myeloid cell function and its therapeutic potential Assess implications for targeting suppressive myeloid populations early to prevent metastatic progressionRead more

day: Conference Day One